American Society of Hematology

2019 ASH-AMFDP Hematology Scholar to Study the Biology of T-Cell Lymphoma

Published on: February 19, 2019

Carlos Murga Zamalloa

(WASHINGTON, February 19, 2019) — The American Society of Hematology (ASH) is pleased to announce that Carlos Murga-Zamalloa, MD, of the University of Michigan Health System has been selected to participate in the American Society of Hematology-Harold Amos Medical Faculty Development Program (ASH-AMFDP), a partnership between ASH and the Robert Wood Johnson Foundation.

Designed to increase the number of underrepresented minority scholars in the field of hematology with academic and research appointments, the ASH-AMFDP provides four-year research awards, totaling $420,000 over the course of the program. Dr. Murga-Zamalloa will spend at least 70 percent of his ASH-AMFDP-funded research under the mentorship of a senior faculty member at his institution.

Dr. Murga-Zamalloa’s research focuses on the biology of T-cell lymphoma, with an emphasis on the role of actin-related signaling during T-cell lymphoma progression. He hopes that his project will result in the discovery of novel signaling pathways that contribute to the progression of T-cell lymphomas, and that this knowledge will lead to future therapeutic approaches. Dr. Murga-Zamalloa currently serves as a house officer of the department of pathology at the University of Michigan Health System in Ann Arbor, Michigan.

“ASH is pleased to support Dr. Murga-Zamalloa and provide him with the resources he needs to reach his career goals in academic research,” said 2019 ASH President Roy Silverstein, MD, of the Medical College of Wisconsin in Milwaukee. “Thanks to our partnership with the Robert Wood Johnson Foundation, ASH is able to support talented scholars from diverse backgrounds whose varied experiences and perspectives help to enrich the field of hematology.”

The ASH-AMFDP program is a component of the ASH Minority Recruitment Initiative, which is dedicated to encouraging diversity in the field of hematology.


The American Society of Hematology (ASH) (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online, as well as the newly launched, online, peer-reviewed open-access journal, Blood Advances (www.bloodadvances.org).

Contact:
Sara Khalaf, American Society of Hematology
skhalaf@hematology.org; 202-552-492

back to top